At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 176 enrolled
Drug / intervention
highly purified human chorionic gonadotropin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Comparing the Efficacy and Safety of Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) for Triggering of Final Follicular Maturation in Women Undergoing Controlled Ovarian Stimulation
In Brief
A Phase 3 clinical trial evaluating highly purified human chorionic gonadotropin and recombinant human chorionic gonadotropin for Infertility. Completed, enrolled 176 participants across 1 site.
Detailed Summary
This trial is investigating the efficacy and safety of highly purified human chorionic gonadotropin (HP-hCG) and recombinant human chorionic gonadotropin (rhCG) for triggering of final follicular maturation in women undergoing controlled ovarian stimulation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesBrazil
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 2015
Enrollment StartApr 2016
Primary CompletionJul 2017
Study CompletionMar 2018
TodayJul 2026
First PostedMay 20, 2015
Enrollment StartApr 1, 2016
Primary CompletionJul 9, 2017
Study CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.1 years ago
Interventions
highly purified human chorionic gonadotropindrug
recombinant human chorionic gonadotropindrug